ASSOCIATION OF BASELINE C-REACTIVE PROTEIN WITH MAINTENANCE OF REMISSION IN PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE TREATED WITH ADALIMUMAB

(1) Univ. of California San Diego

(2) Centre Hosp. Univ. de Lille

(3) ABBOTT



This item was part of the IBD I session at UEG Week Stockholm 2011

This item can be cited as: Gut 2011; 60 (Suppl 3) A195